Navigating the Use of Extracellular Vesicles as Therapeutics

Listicle

Last Updated: August 11, 2022

Written by

Navigating the Use of Extracellular Vesicles as Therapeutics content piece image

To explore and expand options for drug delivery, many are looking to extracellular vesicles (EVs) for their potential as drug encapsulation platforms and vaccine vehicles. EVs are a diverse group of naturally occurring nanoparticles released by cells and possess many characteristics which make them attractive diagnostic and therapeutic candidates.

Download this listicle to learn more about EVs:

As engineerable drug delivery vehicles
As vaccines
From mesenchymal stem cells

Meet the Author

Michele Trott, PhD

Michele Trott (nee Wilson) is a New Zealand-based science writer who pursues freelance writing projects alongside her in-house role as a scientific content writer at Izon Science. After completing her PhD (Endocrinology) at Lincoln University (NZ), Michele began pursuing her science writing career with Technology Networks in the UK. There, she spent 12 months covering a maternity leave role as a science editor, and managed the cell science, biopharma and diagnostics communities. Upon her arrival back in NZ, Michele established “Choice Science Writing” and became a full-time freelance science writer, working with life science marketing agencies, biotech companies – and of course, Technology Networks – to produce engaging articles and blog posts. In April 2021, she took up the opportunity to join the team at Izon Science, a company that enables the precise separation and analysis of extracellular vesicles and other nanoparticles.